SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001583648-18-000012
Filing Date
2018-03-09
Accepted
2018-03-09 06:06:32
Documents
8
Period of Report
2018-03-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm 8-K 24915
2 EXHIBIT 99.1 a180309pieris10kpressrel.htm EX-99.1 16599
3 a180309pieris10kpressrel001.jpg GRAPHIC 175135
4 a180309pieris10kpressrel002.jpg GRAPHIC 197800
5 a180309pieris10kpressrel003.jpg GRAPHIC 165883
6 a180309pieris10kpressrel004.jpg GRAPHIC 217218
7 a180309pieris10kpressrel005.jpg GRAPHIC 77006
8 a180309pieris10kpressrel006.jpg GRAPHIC 89076
  Complete submission text file 0001583648-18-000012.txt   1313551
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37471 | Film No.: 18678400
SIC: 8731 Services-Commercial Physical & Biological Research